Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Ollmann Saphire

Showing results (161-170 of 215) with videos related to

Pageof 22
Sort By:
Plos Pathogens|June 27, 2015
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.
Ebiomedicine|October 1, 2024
Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in miceShailendra Kumar Verma, Fernanda Ana-Sosa-Batiz, Julia Timis, et al.
Cell Reports. Medicine|May 20, 2026
Decoding the human CD4<sup>+</sup> T cell epitope repertoire for Lassa fever virus reveals T cell-based pan-mammarenavirus vaccine candidatesYeji Lee, Leila Siddiqui, Alison Tarke, et al.
Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.
Nature Microbiology|May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER regionAndrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Nature Communications|January 26, 2024
Human coronavirus OC43-elicited CD4<sup>+</sup> T cells protect against SARS-CoV-2 in HLA transgenic miceRúbens Prince Dos Santos Alves, Julia Timis, Robyn Miller, et al.
Science Translational Medicine|October 26, 2022
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virusHaoyang Li, Tierra Buck, Michelle Zandonatti, et al.
Science (New York, N.Y.)|March 15, 2014
Complement is activated by IgG hexamers assembled at the cell surfaceChristoph A Diebolder, Frank J Beurskens, Rob N de Jong, et al.
Cell|October 4, 2020
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCarolyn Rydyznski Moderbacher, Sydney I Ramirez, Jennifer M Dan, et al.
Pageof 22

Showing results (161-170 of 215) with videos related to

Sort By:
Pageof 22
Plos Pathogens|June 27, 2015
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.
Ebiomedicine|October 1, 2024
Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in miceShailendra Kumar Verma, Fernanda Ana-Sosa-Batiz, Julia Timis, et al.
Cell Reports. Medicine|May 20, 2026
Decoding the human CD4<sup>+</sup> T cell epitope repertoire for Lassa fever virus reveals T cell-based pan-mammarenavirus vaccine candidatesYeji Lee, Leila Siddiqui, Alison Tarke, et al.
Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.
Nature Microbiology|May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER regionAndrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Nature Communications|January 26, 2024
Human coronavirus OC43-elicited CD4<sup>+</sup> T cells protect against SARS-CoV-2 in HLA transgenic miceRúbens Prince Dos Santos Alves, Julia Timis, Robyn Miller, et al.
Science Translational Medicine|October 26, 2022
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virusHaoyang Li, Tierra Buck, Michelle Zandonatti, et al.
Science (New York, N.Y.)|March 15, 2014
Complement is activated by IgG hexamers assembled at the cell surfaceChristoph A Diebolder, Frank J Beurskens, Rob N de Jong, et al.
Cell|October 4, 2020
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCarolyn Rydyznski Moderbacher, Sydney I Ramirez, Jennifer M Dan, et al.
Pageof 22